SHC - NASDAQ
Sotera Health Company
$15.27
+0.17%Sotera Health Company provides sterilization, and lab testing and advisory services in the United States, Canada, Europe, and internationally. The company's sterilization services include gamma and electron beam irradiation, and EO processing; Nelson Labs comprise microbiological and analytical chemistry testing; and advisory services for medical device and biopharmaceutical industries. It serves medical devices; pharmaceuticals; food and agricultural products; and commercial, advanced, and specialty application industries. The company was formerly known as Sotera Health Topco, Inc. and changed its name to Sotera Health Company in October 2020. Sotera Health Company was incorporated in 2017 and is headquartered in Broadview Heights, Ohio.
At a Glance
Live SnapshotSotera Health Company Profit Bridge
Profitability Analysis
Gross Margin
Exceptional pricing power and cost management. The company retains over half of revenue after direct costs.
Operating Margin
Outstanding operational efficiency. The company generates substantial profit from core operations.
Net Profit Margin
Moderate profitability with room for improvement. Monitor interest expenses and tax efficiency.
Effective Tax Rate
Higher tax burden may reflect limited tax optimization or operations in high-tax jurisdictions.
Profitability Insight
High margin compression: Large gap between gross and net margins suggests operational inefficiencies or heavy debt burden. Focus on expense management and deleveraging.
Sotera Health Company Income Statement
SHC • NASDAQ
| Sotera Health Company Income Statement | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 |
|---|---|---|---|---|---|---|---|---|
REVENUE | ||||||||
1.2B | 1.1B | 1B | 1B | 931.5M | 818.2M | 778.3M | 746.1M | |
GROSS PROFIT | ||||||||
(518.1M) | (498.1M) | (472.1M) | (446.7M) | (412.8M) | (374.6M) | (382.9M) | (388.9M) | |
645.5M | 602.3M | 577.2M | 557M | 518.7M | 443.6M | 395.4M | 357.3M | |
OPERATING INCOME | ||||||||
(252.8M) | (304.7M) | (300.5M) | (308.7M) | (261.9M) | (237.6M) | (211.8M) | (191.3M) | |
(252.8M) | (242.6M) | (236.7M) | (245.7M) | (198.2M) | (178.5M) | (147.5M) | (133.4M) | |
392.8M | 297.6M | 276.7M | 248.4M | 256.7M | 206M | 183.6M | 80.8M | |
PRE-TAX INCOME | ||||||||
(155.7M) | (164.7M) | (142.9M) | (80.1M) | (74.2M) | (215.3M) | (157.7M) | (143.3M) | |
-155.7M | -164.7M | -142.9M | -80.1M | -74.2M | -215.3M | -157.7M | -143.3M | |
(0.0) | (62M) | (63.8M) | (62.9M) | (63.8M) | (59M) | (64.4M) | (143M) | |
-245.3M | -183.8M | -170.7M | -491.5M | -81M | -244.9M | -184.5M | -56.6M | |
147.5M | 113.9M | 106M | -243.1M | 175.7M | -38.9M | -916K | 24.2M | |
NET INCOME | ||||||||
(69.6M) | (69.5M) | (54.7M) | -9.5M | (58.6M) | -1.4M | (19.5M) | (30.1M) | |
77.9M | 44.4M | 51.4M | -233.6M | 116.9M | -38.6M | -20.9M | -5.9M |
SEC Filings
SHC - Filing history and reports
| Filing Type | Filing Date | Period Ending | Fiscal Year | Actions |
|---|---|---|---|---|
8-K 8-K 2026 N/A | May 22, 2026 | May 21, 2026 | 2026 | |
8-K 8-K 2026 N/A | May 20, 2026 | May 20, 2026 | 2026 | |
8-K 8-K 2026 N/A | May 13, 2026 | May 11, 2026 | 2026 | |
10-Q 10-Q 2026 Q1 Q1 | May 05, 2026 | March 31, 2026 | 2026 | |
8-K 8-K 2026 N/A | May 05, 2026 | April 30, 2026 | 2026 | |
DEF 14A DEF 14A 2026 N/A | April 08, 2026 | May 21, 2026 | 2026 | |
8-K 8-K 2026 N/A | March 16, 2026 | March 12, 2026 | 2026 | |
8-K 8-K 2026 N/A | March 06, 2026 | March 04, 2026 | 2026 | |
10-K 10-K 2025 FY FY | February 24, 2026 | December 31, 2025 | 2025 | |
8-K 8-K 2026 N/A | February 24, 2026 | February 18, 2026 | 2026 |
Related Guides
Continue your SHC research with focused valuation guides.
Research Paths
Snapshot
Start with context, operating signals, and key market metrics.
Value Model
Stress test fair value across bear, base, and bull assumptions.
Statements
Validate revenue quality, margins, and balance sheet durability.
Earnings Call
Read management commentary and compare it with reported outcomes.
Dividends
Check payout sustainability and long-term distribution behavior.
Analyst Expectations
Review consensus spread and where estimate risk is concentrated.